Insulet International
Budget
€50 — €0
EP Access
0
accredited persons
Staff
2
0.2 FTE
EU Grants
None
Mission & Goals
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery (up to 72 hours), without the need to see or handle a needle.
EU Legislative Interests
European Health Data Space Artificial Intelligence Act Diabetes related policies Any regulation relating to medical devices & healthcare
Communication Activities
N/A
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
MedTech Europe www.medtecheurope.org EUDF https://www.eudf.org/
Organisation Members
MedTech Europe www.medtecheurope.org
Additional Information
The cost outlined above is reflective of activity and membership fee with MedTech Europe (our industry association)
Commissioner Meetings
No recorded meetings with EU commissioners.